Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma (BOSTON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03110562
Recruitment Status : Active, not recruiting
First Posted : April 12, 2017
Last Update Posted : September 30, 2019
Sponsor:
Information provided by (Responsible Party):
Karyopharm Therapeutics Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2020